DELSTRIGO

DORAVIRINE, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for DELSTRIGO, covering 2018-08-30 to 2025-12-03. Get the full timeline:

Most recent: EMA Authorised: Delstrigo (doravirine;lamivudine;tenofovir disoproxil fumarate) — Merck Sharp & Dohme B.V.